Overview

Study for Beinaglutide Versus Glargine Therapy in Glycemic Variability of Type 2 Diabetes Mellitus

Status:
Recruiting
Trial end date:
2020-12-04
Target enrollment:
Participant gender:
Summary
The investigators aimed to assess the efficacy and safety of Beinaglutide versus glargine , in individuals with type 2 diabetes who did not achieve adequate glycaemic control with oral antidiabetic drug.
Phase:
N/A
Details
Lead Sponsor:
Xijing Hospital
Treatments:
Insulin Glargine